MGDI Trademark

Trademark Overview

On Monday, March 18, 2019, a trademark application was filed for MGDI with the United States Patent and Trademark Office. The USPTO has given the MGDI trademark a serial number of 88344375. The federal status of this trademark filing is REGISTERED as of Tuesday, December 20, 2022. This trademark is owned by MGD Innovations, LLC. The MGDI trademark is filed in the Medical Instrument Products and Education & Entertainment Services categories with the following description:

Educational services, namely, conducting presentations, lectures, classes, seminars and workshops in the fields of ophthalmology, meibomian glands, dry eye and eye disease for the purpose of monitoring, analyzing, diagnosing and treatment and distribution of course and educational materials in connection therewith; providing a website featuring non-downloadable videos in the field of meibomian gland dysfunction and dry eye treatment

Medical devices, namely, devices for analyzing, diagnosing, treating and monitoring dry eye and meibomian gland dysfunction; Medical devices, namely, devices for relieving and expressing obstructions or occlusions from meibomian glands
mgdi

General Information

Serial Number88344375
Word MarkMGDI
Filing DateMonday, March 18, 2019
Status700 - REGISTERED
Status DateTuesday, December 20, 2022
Registration Number6931345
Registration DateTuesday, December 20, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2019

Trademark Statements

Goods and ServicesEducational services, namely, conducting presentations, lectures, classes, seminars and workshops in the fields of ophthalmology, meibomian glands, dry eye and eye disease for the purpose of monitoring, analyzing, diagnosing and treatment and distribution of course and educational materials in connection therewith; providing a website featuring non-downloadable videos in the field of meibomian gland dysfunction and dry eye treatment
Pseudo MarkMEIBOMIAN GLAND DYSFUNCTION INNOVATIONS
Goods and ServicesMedical devices, namely, devices for analyzing, diagnosing, treating and monitoring dry eye and meibomian gland dysfunction; Medical devices, namely, devices for relieving and expressing obstructions or occlusions from meibomian glands

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, April 5, 2019
Primary Code010
First Use Anywhere DateWednesday, May 25, 2022
First Use In Commerce DateWednesday, May 25, 2022
International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, April 5, 2019
Primary Code041
First Use Anywhere DateTuesday, May 12, 2020
First Use In Commerce DateWednesday, May 25, 2022

Trademark Owner History

Party NameMGD Innovations, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTampa, FL 33609
Party NameMGD Innovations, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTampa, FL 33609
Party NameMGD Innovations, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTampa, FL 33609

Trademark Events

Event DateEvent Description
Tuesday, December 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 20, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, December 7, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, November 15, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, November 14, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 12, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, September 23, 2022USE AMENDMENT FILED
Wednesday, October 12, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 4, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, September 23, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, March 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 21, 2022SOU EXTENSION 5 GRANTED
Thursday, March 10, 2022SOU EXTENSION 5 FILED
Monday, March 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 10, 2022TEAS EXTENSION RECEIVED
Saturday, September 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 9, 2021SOU EXTENSION 4 GRANTED
Thursday, September 9, 2021SOU EXTENSION 4 FILED
Thursday, September 9, 2021TEAS EXTENSION RECEIVED
Saturday, February 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 25, 2021SOU EXTENSION 3 GRANTED
Thursday, February 25, 2021SOU EXTENSION 3 FILED
Thursday, February 25, 2021TEAS EXTENSION RECEIVED
Friday, September 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 16, 2020SOU EXTENSION 2 GRANTED
Wednesday, September 16, 2020SOU EXTENSION 2 FILED
Wednesday, September 16, 2020TEAS EXTENSION RECEIVED
Thursday, February 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 25, 2020SOU EXTENSION 1 GRANTED
Tuesday, February 25, 2020SOU EXTENSION 1 FILED
Tuesday, February 25, 2020TEAS EXTENSION RECEIVED
Tuesday, September 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 21, 2019ASSIGNED TO LIE
Monday, June 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 5, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, June 5, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 5, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, June 5, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 29, 2019ASSIGNED TO EXAMINER
Friday, April 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 21, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

mgdi devices meibomian namely monitoring gland analyzing diagnosing educational treatment dysfunction